Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

Sponsor
New York State Psychiatric Institute (Other)
Overall Status
Completed
CT.gov ID
NCT00018863
Collaborator
National Institute of Mental Health (NIMH) (NIH)
165
6
68
27.5
0.4

Study Details

Study Description

Brief Summary

This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Young children age 3-5.5 years will be studied. The study includes treatment with different doses of methylphenidate and placebo; all children will receive active medication during the study. Prior to treatment, each child will receive a thorough psychiatric evaluation and each guardian will complete a 10-week workshop (2 hours/week). Throughout the study, parents and teachers will complete forms that report on the child's behavior and possible side effects. Participants will be monitored by regular visits with a study physician. Most participants will be involved in the study for up to 16 months to ensure optimal evaluation, dosing, and monitoring

Study Design

Study Type:
Interventional
Allocation:
Randomized
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Methylphenidate Efficacy and Safety in ADHD Preschoolers
Actual Study Start Date :
Apr 1, 2001
Actual Primary Completion Date :
Mar 31, 2006
Actual Study Completion Date :
Nov 30, 2006

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 5 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Boys and girls who are:
    • Between the ages of 3-5.5 years

    • Qualified as having ADHD by our diagnostic evaluations and clinical staff

    • Otherwise generally healthy

    • Willing, and have parents that are willing, to attend all visits required by the study

    • Enrolled in some type of day-program: day care, preschool, nursery school, kindergarten, for at least 2 half days/week

    • In classrooms with teachers that are willing to participate by completing rating scale

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of California, Irvine Irvine California United States
    2 University of California, Los Angeles Los Angeles California United States
    3 Johns Hopkins University Baltimore Maryland United States
    4 New York State Psychiatric Institute New York New York United States
    5 New York University School of Medicine New York New York United States
    6 Duke University Medical Center Durham North Carolina United States

    Sponsors and Collaborators

    • New York State Psychiatric Institute
    • National Institute of Mental Health (NIMH)

    Investigators

    • Study Chair: Laurence Greenhill, M.D.,

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Laurence Greenhill, Professor of Clinical Child and Adolescent Psychiatry, New York State Psychiatric Institute
    ClinicalTrials.gov Identifier:
    NCT00018863
    Other Study ID Numbers:
    • #3761
    • U01MH060903
    • U01MH060642
    • U01MH060943
    • U01MH060848
    • U01MH060900
    • U01MH060833
    • DSIR CT-M2
    First Posted:
    Jul 9, 2001
    Last Update Posted:
    Dec 2, 2020
    Last Verified:
    Nov 1, 2020
    Keywords provided by Laurence Greenhill, Professor of Clinical Child and Adolescent Psychiatry, New York State Psychiatric Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 2, 2020